Key Financial Data Of Group

Cyfuse Biomedical K.K. - Filing #7311816

Concept As at
2024-06-30
2024-01-01 to
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-06-30
2023-01-01 to
2023-06-30
Key financial data of group
Business results of group
Net sales
18,042,000 JPY
61,112,000 JPY
18,272,000 JPY
Ordinary profit (loss)
-445,993,000 JPY
-586,187,000 JPY
-362,953,000 JPY
Net assets
2,931,033,000 JPY
3,203,469,000 JPY
3,410,644,000 JPY
Total assets
3,844,751,000 JPY
4,214,809,000 JPY
4,386,406,000 JPY
Basic earnings (loss) per share
-56.15
-75.42
-46.73
Diluted earnings per share
Equity-to-asset ratio
0.756 xbrli:pure
0.760 xbrli:pure
0.777 xbrli:pure
Net cash provided by (used in) operating activities
-371,740,000 JPY
-562,296,000 JPY
-315,940,000 JPY
Net cash provided by (used in) investing activities
-7,821,000 JPY
-19,474,000 JPY
-11,347,000 JPY
Net cash provided by (used in) financing activities
-108,809,000 JPY
18,236,000 JPY
-53,418,000 JPY
Cash and cash equivalents
2,385,402,000 JPY
2,873,773,000 JPY
3,056,601,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.